Utilization of Antidiabetic Drugs among Medicare Beneficiaries with Diabetes, 2006-2009. Diabetes Treatment: Data Points 9.

摘要

Biguanides (i.e., metformin) were the most commonly used antidiabetic drug class among Medicare beneficiaries from 2006 to 2009, followed by sulfonylureas, insulins, and thiazolidinediones. Approximately 37 percent of diabetic beneficiaries had a claim for a biguanide in 2009. Sulfonylurea use generally increased with age. Among Medicare beneficiaries age 85 years or older, sulfonylureas were used more frequently than both biguanides and insulins from 2006 to 2009. From 2006 to 2009, thiazolidinedione use decreased dramatically overall and uniformly across all health care referral regions in the U.S. This trend was consistent among all age groups.